Warp Speed funded ~$800 million in R&D and $1.5 billion for Moderna to make 100 million doses — whether it is approved or not.
Similarly, Pfizer received $1.95 billion to make 100 million doses whether it was approved or not. (EDIT: Pfizer’s agreement is an advance purchase but unlike Moderna’s it is contingent on FDA approval.)
Warp Speed provided ~$5 billion in guaranteed prepayments which meant the companies could ramp up manufacturing without waiting for approval first in order to have a large number of doses ready by the end of the year.
That’s never been done before, but the bet has certainly paid off spectacularly so far.
Novavax got $1.6 billion and GSK got $2 billion for another 100 million doses each.
Assuming all 4 companies produce highly effective vaccines, the US has prepaid for 400mm doses / 200mm courses of vaccine. This will save a lot of lives not just in the US but worldwide as well, because it shifts the manufacturing curve sooner until the point where several billion doses have been made.
Similarly, Pfizer received $1.95 billion to make 100 million doses whether it was approved or not. (EDIT: Pfizer’s agreement is an advance purchase but unlike Moderna’s it is contingent on FDA approval.)
Warp Speed provided ~$5 billion in guaranteed prepayments which meant the companies could ramp up manufacturing without waiting for approval first in order to have a large number of doses ready by the end of the year.
That’s never been done before, but the bet has certainly paid off spectacularly so far.
Novavax got $1.6 billion and GSK got $2 billion for another 100 million doses each.
Assuming all 4 companies produce highly effective vaccines, the US has prepaid for 400mm doses / 200mm courses of vaccine. This will save a lot of lives not just in the US but worldwide as well, because it shifts the manufacturing curve sooner until the point where several billion doses have been made.